SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation ...

SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company”), a surgical robotics company focused on advancing patient care by developing ...

Procept Biorobotics Corp reported a disappointing fourth quarter for 2025, with earnings per share (EPS) falling short of expectations at -$0.53 compared to the forecast of -$0.32. Revenue also missed ...

PROCEPT BioRobotics (NASDAQ:PRCT) is preparing to release its quarterly earnings on Tuesday, 2026-02-24. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...

Based on the one-year price targets offered by 12 analysts, the average target price for PROCEPT BioRobotics Corp (NASDAQ:PRCT) is $52.75 with a high estimate of $75.00 and a low estimate of $38.00.

Procept Biorobotics Corp’s stock reached a significant milestone, hitting a 52-week low at 27.79 USD. This development marks a notable decline for the company, as the stock has experienced a ...

Total revenue of $83.3 million for the third quarter of 2025, an increase of 43% compared to the prior year period in 2024 U.S. handpiece and consumables revenue of $44.4 million for the third quarter ...

Chicago Capital added 999,873 shares of Procept BioRobotics with an estimated purchase value of $45.65 million based on the average price for the quarter. The transaction represents a trade size equal ...